within Pharmacolibrary.Drugs.ATC.D;

model D07AB01
  extends Pharmacokinetic.Models.PK_1C(
    weight         = 70,
    F              = 1,
    Cl             = 0.0,
    adminDuration  = 600,
    adminMass      = 0.5 / 1000000,   // mg → kg
    adminCount     = 1,
    Vd             = 0.001,
    Cmin           = 0.001,
    Cmax           = 0.01,
    Ctox_peak      = 0.02,
    Ctox_trough    = 0.01
  );

  annotation (Documentation(
    info       = "<html><body><table><tr><td>Drug:</td><td>D07AB01</td></tr><td>route:</td><td>topical</td></tr><tr><td>n-compartments</td><td>1</td></tr></table><p>Clobetasone is a topical corticosteroid primarily used to reduce inflammation and itching caused by various skin conditions such as eczema and dermatitis. It is approved for topical use in several countries, but not available or approved in the United States. The most common formulation is clobetasone butyrate 0.05% cream or ointment.</p><h4>Pharmacokinetics</h4><p>No dedicated clinical pharmacokinetic studies in humans reporting compartmental PK parameters, bioavailability, or clearance exist for topical clobetasone butyrate. Most data suggest limited systemic absorption after application to intact human skin.</p><h4>References</h4><ol><li><p>Rink, H, et al., &amp; Hockwin, O (1989). Distribution of clobetasone in rabbit eye tissues after topical application. <i>Lens and eye toxicity research</i> 6(1-2) 353–363. PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/2488027/\">https://pubmed.ncbi.nlm.nih.gov/2488027</a></p></li><li><p>Hehir, M, et al., &amp; Shenoy, EV (1983). Investigation of the pharmacokinetics of clobetasol propionate and clobetasone butyrate after a single application of ointment. <i>Clinical and experimental dermatology</i> 8(2) 143–151. DOI:<a href=\"https://doi.org/10.1111/j.1365-2230.1983.tb01758.x\">10.1111/j.1365-2230.1983.tb01758.x</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/6851236/\">https://pubmed.ncbi.nlm.nih.gov/6851236</a></p></li><li><p>Sparidans, RW, et al., &amp; Beijnen, JH (2010). Liquid chromatography-tandem mass spectrometric assay for clobetasol propionate in human serum from patients with atopic dermatitis. <i>Journal of chromatography. B, Analytical technologies in the biomedical and life sciences</i> 878(23) 2150–2154. DOI:<a href=\"https://doi.org/10.1016/j.jchromb.2010.06.011\">10.1016/j.jchromb.2010.06.011</a>  PUBMED:<a href=\"https://pubmed.ncbi.nlm.nih.gov/20605116/\">https://pubmed.ncbi.nlm.nih.gov/20605116</a></p></li></ol></body></html>",
    revisions  = "<html><body><ul><li>06/2025 initial model generated by LLM gpt-4.1 from general data</li></ul></body></html>"
  ));
end D07AB01;
